Natural Pain Relieving Cream
Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.
Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.
2,760 recalls, newest first.
Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.
Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.
Failed Dissolution Specifications
Out of specification for assay
Cross Contamination with Other Products
Cross Contamination with Other Products
Cross Contamination with Other Products
Cross Contamination with Other Products
Sub-potent Drug; powder discoloration associated with decreased potency
Sub-potent Drug; powder discoloration associated with decreased potency
Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Lack of Assurance of Sterility: leaking bags
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.